Impact of ABCC2, ABCG2 and SLCO1B1 Polymorphisms on the Pharmacokinetics of Pitavastatin in Humans

Lack of association between ABCC2 gene variants and treatment response in epilepsy

(2012) Eva Hilger et al.   PHARMACOGENOMICS

Drug Transporters in Drug Efficacy and Toxicity

(2011) M.K. DeGorter et al.   Annual Review of Pharmacology and Toxicology

Differential Effect of Grapefruit Juice on Intestinal Absorption of Statins Due to Inhibition of Organic Anion Transporting Polypeptide and/or P-glycoprotein

(2011) Yoshiyuki Shirasaka et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy

(2011) Mike Ufer et al.   Pharmacogenetics and Genomics

Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients

(2010) Guo-ping Yang et al.   ACTA PHARMACOLOGICA SINICA

New Drug Approvals: Pitavastatin: A New HMG-CoA Reductase Inhibitor

(2010) Terri M Wensel et al.   ANNALS OF PHARMACOTHERAPY

Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study

(2010) L A Donnelly et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Decreased Hepatic Breast Cancer Resistance Protein Expression and Function in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats

(2010) W. Yue et al.   DRUG METABOLISM AND DISPOSITION

Intestinal Absorption of HMG-CoA Reductase Inhibitor Pitavastatin Mediated by Organic Anion Transporting Polypeptide and P-Glycoprotein/Multidrug Resistance 1

(2010) Yoshiyuki Shirasaka et al.   Drug Metabolism and Pharmacokinetics

Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function

(2010) S Laechelt et al.   PHARMACOGENOMICS JOURNAL

Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs

(2009) Ichiro Ieiri et al.   Expert Opinion on Drug Metabolism & Toxicology

OATP1B1 388A>G polymorphism and pharmacokinetics of pitavastatin in Chinese healthy volunteers

(2009) J. Wen et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

The 5'-Untranslated Region of Multidrug Resistance Associated Protein 2 (MRP2; ABCC2) Regulates Downstream Open Reading Frame Expression through Translational Regulation

(2009) Y. Zhang et al.   MOLECULAR PHARMACOLOGY

Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 −24C>T polymorphism in young and adult patients with epilepsy

(2009) Mike Ufer et al.   Pharmacogenetics and Genomics

Genetic variations and gene expression of transporters in drug disposition and response

(2008) Ying Huang et al.   Expert Opinion on Drug Metabolism & Toxicology

The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15

(2008) Jian Wei Deng et al.   Pharmacogenetics and Genomics